Conference Coverage

IV superior to oral treatment for iron deficiency during pregnancy


 

REPORTING FROM ACOG 2018


While the analysis, according to Dr. Govindappagari, has merit, she and her team did not have access to relevant blinded, randomly controlled trials, which may have affected the findings. Maternal and neonatal outcomes were also not included in any of the studies analyzed, nor was a cost analysis of the financial burden of switching from oral to intravenous treatment.

Despite these limitations, Dr. Govindappagari and her colleagues assert the use of intravenous iron could have a significant effect on this problem.

“Intravenous iron compared to oral iron has a higher number reach target, a greater increase in hemoglobin, and has fewer side effects,” Dr. Govindappagari said to attendees. “This could be particularly useful in women in labor, during the third trimester, and women who are iron deficient and are at risk for postpartum hemorrhage.”

Dr. Govindappagari and her colleagues reported no relevant financial disclosures.

SOURCE: Govindappagari S et al. ACOG 2018, Abstract 10OP.

Pages

Recommended Reading

Axial SpA disease activity remains mostly stable throughout pregnancy
MDedge Internal Medicine
MDedge Daily News: Why most heart failure may be preventable
MDedge Internal Medicine
Higher preconception blood pressure linked to pregnancy loss
MDedge Internal Medicine
Reassurance for women taking certolizumab during pregnancy
MDedge Internal Medicine
Zika virus: Sexual contact risk may be limited to short window
MDedge Internal Medicine
Studying the gestational diabetes risk associated with endocrine-disrupting chemicals
MDedge Internal Medicine
Hints of altered microRNA expression in women exposed to EDCs
MDedge Internal Medicine
Time to scrap LMWH for prevention of placenta-mediated pregnancy complications?
MDedge Internal Medicine
MDedge Daily News: Fewer smokes mean fewer strokes
MDedge Internal Medicine
MDedge Daily News: How to handle opioid constipation
MDedge Internal Medicine